Here are 2 shares to buy and hold for my ISA portfolio

I’ve chosen these two shares to buy and hold for my ISA portfolio as I’m confident about their long-term growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve been looking for shares to buy and hold with the ISA deadline fast approaching late on Tuesday, and the new financial year starting on Wednesday. While the market has recovered since Russia’s invasion of Ukraine, I think there are still plenty of undervalued stocks out there.

The two shares I wanted to discuss today are Bank of Georgia (LSE:BGEO) and Smith & Nephew (LSE:SN). Both of them are trading at a discount. But more importantly, I’m confident on the long-term prospects of these two firms.

Bank of Georgia

The Bank of Georgia share price had outperformed the market prior to Russia’s invasion. In fact, over the year to February, the Tbilisi-based bank had risen by nearly 40%. However, events in Ukraine sent the share price crumbling despite minimal impact on its operations.

For me, it appears that the market can’t see beyond Russia-induced volatility on this one. The Bank of Georgia looks very cheap with a price-to-earnings (P/E) ratio of just 3.3. However, even prior to the war in Ukraine, the bank’s P/E ratio remained below five, considerably less than most established western financial organisations.

Performance has been good with 2021 seeing the bank’s revenue exceed pre-pandemic levels. This was also reflected in pre-tax profits, which stood at £192m, more than any year in the last five.

The bank’s share price is also heavily influenced by Georgian economic data. Last week, its Office for National Statistics recorded that the economy had grown by 14.6% year-on-year. While average real GDP growth was equal to 16.3% over the year. Thus, the bank is operating in fast-growth market.

Moreover, it is worth noting that Georgia has attempted not to aggravate its northern neighbour, Russia. Tbilisi has said it wouldn’t impose sanctions on Russia, but claims it is in full compliance with the financial measures imposed by the international community. Russia and Georgia had not enjoyed good relations in recent history, especially since the 2008 Russo-Georgian war.

I have recently bought shares in the bank.

Smith & Nephew

I believe Smith & Nephew has considerable upside potential because of the pent-up demand for elective surgeries owing to pandemic-induced delays. As I write, the medical devices giant is trading at around 1,229p per share, considerably discounted from a year-high of 1,592p in July 2021.

In fact, prior to the Covid-19 pandemic, the London-headquartered firm almost saw its share price push beyond 2,000p for the first time.

Despite a tough operating environment over the past two years, Smith and Nephew still returned a profit in 2020 and 2021. And although 2021 saw further Covid-induced disruption, particularly at the beginning of the year, the firm posted a $586m pre-tax profit. The figure represents good progress but some distance behind the $743m recorded in 2019.

I think Smith & Nephew is well-positioned to benefit from the current situation. In England alone, there are now more than six million people waiting for elective procedures. Moreover, there is considerable political will to reduce the waiting list.

I’m confident it will profit from the pent-up demand in 2022 and further into the future. Having said that, I accept there are risks, including the emergence of new Covid variants.

I own shares in Smith & Nephew in my pension and will be looking to purchase more for my ISA.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Fox owns shares in Bank of Georgia and Smith & Nephew. The Motley Fool UK has recommended Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

“The last FTSE 100 stock I’d sell in a recession is…”

It's well worth considering some recession-resiliant stocks as part of a diversifed portfolio. Here, our free-site writers offer up their…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

The Lloyds share price is flying! What can go wrong?

After years in the doldrums, the Lloyds share price is finally on the up. Now Harvey Jones is wondering how…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

2 of the best AIM growth stocks to consider buying in April

Looking for brilliant growth stocks to buy? Royston Wild has identified two top AIM companies whose share prices are ripping…

Read more »

Young black man looking at phone while on the London Overground
Investing Articles

Penny stocks: 1 I own and 1 I’d love to buy

Sumayya Mansoor explains why she likes these two penny stocks for her holdings. One, she’s hoping to buy, and the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

1 under-the-radar dividend stock yielding over 5% I’ve got my eye on

This Fool explains why this dividend stock has caught her eye with its potentially attractive level of return and exciting…

Read more »

Investing Articles

9% and 7% yields! 2 income stocks investors should consider buying

Income stocks are a great way to build wealth. Our writer explains why investors aiming to do this should look…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

What’s going on with Tesla stock?

Tesla stock has fallen by over a quarter so far this year. Yet our writer sees a lot to like.…

Read more »

Investing Articles

If I’d invested £5,000 in Aviva shares 1 year ago, here’s what I’d have now

This writer highlights two reasons why Aviva shares may well be worth considering for a passive income portfolio right now.

Read more »